Primary efficacy endpoint will be time to hemostasis.
be safety (complication rate) and satisfaction of patients regarding time to sitting incline and time to ambulation. 25% of patients from each arm will be randomized for Duplex examination of the femoral artery at the access site.
18 Years to 80 Years (Adult, Senior)
July 16, 2008
August 16, 2011
Meir Medical Center Kfar-Saba, Israel
† Study has passed its completion date and status has not been verified in more than two years.